{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:00:02Z","timestamp":1781816402851,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ccc.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:47:22Z","timestamp":1781815642000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sepsis and the Immunocompromised Host"],"prefix":"10.1016","author":[{"given":"Ann","family":"Zalucky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Leligdowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laveena","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ccc.2026.05.007_bib1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S2213-2600(25)00124-9","article-title":"Sepsis in patients who are immunocompromised: diagnostic challenges and future therapies","volume":"13","author":"Deinhardt-Emmer","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.ccc.2026.05.007_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of immunosuppression among US adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ccc.2026.05.007_bib3","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.ccc.2026.05.007_bib4","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1200\/JCO.2005.01.487","article-title":"Outcome of cancer patients considered too well for intensive care unit admission","volume":"23","author":"Thi\u00e9ry","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ccc.2026.05.007_bib5","first-page":"195","article-title":"Outcome of critically ill patients with haematological malignancies referred to critical care: impact of timing of admission","volume":"16","author":"Metaxa","year":"2015","journal-title":"J Intensive Care Soc"},{"issue":"7","key":"10.1016\/j.ccc.2026.05.007_bib6","first-page":"1586","article-title":"Intensive care unit outcomes in patients with malignancies","volume":"42","author":"Dumas","year":"2014","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2026.05.007_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2026.05.007_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-induced immunosuppression","volume":"84","author":"Torres","year":"2022","journal-title":"Annu Rev Physiol"},{"issue":"11","key":"10.1016\/j.ccc.2026.05.007_bib9","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ccc.2026.05.007_bib10","first-page":"e45","article-title":"Defining and categorizing immunocompromised patients in critical care","volume":"13","author":"Shankar-Hari","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccc.2026.05.007_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/cc7713","article-title":"Characteristics and outcomes of cancer patients in European ICUs","volume":"13","author":"Taccone","year":"2009","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.ccc.2026.05.007_bib12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00134-014-3471-9","article-title":"Survival in solid cancer patients following intensive care unit admission","volume":"40","author":"Puxty","year":"2014","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.ccc.2026.05.007_bib13","article-title":"Emergency department visits among cancer patients in the United States, 2006\u20132012","volume":"13","author":"Rivera","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccc.2026.05.007_bib14","first-page":"1","article-title":"Cancer patients in the intensive care unit: outcomes and predictors of mortality","volume":"26","author":"Williams","year":"2010","journal-title":"Crit Care Clin"},{"issue":"10","key":"10.1016\/j.ccc.2026.05.007_bib15","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Clinical impact of febrile neutropenia in patients with cancer","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ccc.2026.05.007_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/CCM.0000000000000714","article-title":"Severe sepsis in hematopoietic stem cell transplant recipients","volume":"43","author":"Kumar","year":"2015","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2026.05.007_bib17","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","article-title":"A consensus immune dysregulation framework for sepsis and critical illnesses","volume":"31","author":"Moore","year":"2025","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ccc.2026.05.007_bib18","first-page":"e321","article-title":"Inflammatory phenotypes in immunocompromised patients with sepsis","volume":"52","author":"Ronner","year":"2024","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccc.2026.05.007_bib19","first-page":"e457","article-title":"Hyperinflammatory and hypoinflammatory subphenotypes in immunocompromised sepsis","volume":"52","author":"Weingart","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2026.05.007_bib20","article-title":"Clinical features, etiology and outcomes of infections in neutropenic cancer patients","volume":"8","author":"Gudiol","year":"2021","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.ccc.2026.05.007_bib21","first-page":"2503","article-title":"Prognostic value of proadrenomedullin in critically ill patients with cancer and sepsis","volume":"42","author":"Debiane","year":"2014","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2026.05.007_bib22","doi-asserted-by":"crossref","first-page":"R816","DOI":"10.1186\/cc3885","article-title":"Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia","volume":"9","author":"Christ-Crain","year":"2005","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2026.05.007_bib23","first-page":"401","article-title":"High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia","volume":"31","author":"Self","year":"2013","journal-title":"AJEM (Am J Emerg Med)"},{"issue":"2","key":"10.1016\/j.ccc.2026.05.007_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2026.05.007_bib25","first-page":"638","article-title":"Diagnostic yield and safety of bronchoscopy in immunocompromised patients with acute respiratory failure: a secondary analysis of the EFRAIM study","volume":"45","author":"Bauer","year":"2019","journal-title":"Intensive Care Med"},{"issue":"16","key":"10.1016\/j.ccc.2026.05.007_bib26","first-page":"1711","article-title":"Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized clinical trial (EPIC)","volume":"314","author":"Azoulay","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccc.2026.05.007_bib27","first-page":"103","article-title":"Diagnostic yield and safety of open lung biopsy in ICU patients with acute respiratory failure","volume":"35","author":"Papazian","year":"2007","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2026.05.007_bib28","first-page":"1976","article-title":"Open lung biopsy in critically ill patients with diffuse lung disease: a systematic review","volume":"100","author":"Wong","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ccc.2026.05.007_bib29","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3904\/kjim.2018.438","article-title":"Modified early warning score with SpO2\/FiO2 ratio predicts ICU admission in hematologic malignancy patients","volume":"35","author":"Lee","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"6","key":"10.1016\/j.ccc.2026.05.007_bib30","first-page":"1416","article-title":"Diagnosis and prevention of invasive fungal infections in the immunocompromised host","volume":"162","author":"Wahab","year":"2022","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccc.2026.05.007_bib31","article-title":"Epidemiology and outcome of invasive fungal infections in transplant recipients","volume":"21","author":"Neofytos","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.ccc.2026.05.007_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.ccc.2026.05.007_bib33","first-page":"e210","article-title":"Continuation versus temporary interruption of immunomodulatory therapy during infection in rheumatoid arthritis","volume":"80","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.ccc.2026.05.007_bib34","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis","volume":"23","author":"Clark","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ccc.2026.05.007_bib35","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ccc.2026.05.007_bib36","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone\u2013treated donors in neutropenic patients with infection (RING study)","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ccc.2026.05.007_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0044-1787992","article-title":"Informative subtyping of patients with sepsis","volume":"45","author":"Cafferkey","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2026.05.007_bib38","first-page":"173","article-title":"Viral infections in immunocompromised hosts","volume":"2021","author":"Chemaly","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.ccc.2026.05.007_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2110-5820-1-5","article-title":"Intensive care of the cancer patient: recent achievements and remaining challenges","volume":"1","author":"Azoulay","year":"2011","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ccc.2026.05.007_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13613-024-01366-3","article-title":"Factors associated with cancer treatment resumption after ICU stay in patients with solid tumors","volume":"14","author":"Benguerfi","year":"2024","journal-title":"Ann Intensive Care"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070426000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070426000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:47:33Z","timestamp":1781815653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070426000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0749070426000369"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2026.05.007","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sepsis and the Immunocompromised Host","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}